Shannath L Merbs, MD | |
600 N Wolfe St, Baltimore, MD 21287-0005 | |
(410) 955-5080 | |
Not Available |
Full Name | Shannath L Merbs |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 31 Years |
Location | 600 N Wolfe St, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750330502 | NPI | - | NPPES |
504300000 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | D47976 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Md Medical Center Midtown Campus | Baltimore, MD | Hospital |
University Of Maryland Medical Center | Baltimore, MD | Hospital |
University Of Md St Joseph Medical Center | Towson, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Maryland Eye Associates | 7719948835 | 21 |
News Archive
More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy, when anti-seizure medications don't work, according to a Rutgers coauthored study that may help lead to tailored treatments.
A new study describes the beneficial effect of an extract of Artemisia annua when used to treat cells in culture exposed to SARS-CoV-2.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
As part of its plan to expand access to a wide array of outpatient services, NYU Langone Medical Center has opened a new 327,000 square-foot Ambulatory Care Center (ACC) at 240 East 38th Street.
Researchers at Charité - Universitätsmedizin Berlin have developed a biophysical treatment method that allows up to 50 percent more toxins to be removed from the blood of dialysis patients. Use of this technology may result in patients with kidney disease seeing a considerable reduction in the length of dialysis sessions. An initial patent application for this technology was filed in 2011.
› Verified 6 days ago
Entity Name | University Of Maryland Eye Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285655829 PECOS PAC ID: 7719948835 Enrollment ID: O20041022000122 |
News Archive
More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy, when anti-seizure medications don't work, according to a Rutgers coauthored study that may help lead to tailored treatments.
A new study describes the beneficial effect of an extract of Artemisia annua when used to treat cells in culture exposed to SARS-CoV-2.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
As part of its plan to expand access to a wide array of outpatient services, NYU Langone Medical Center has opened a new 327,000 square-foot Ambulatory Care Center (ACC) at 240 East 38th Street.
Researchers at Charité - Universitätsmedizin Berlin have developed a biophysical treatment method that allows up to 50 percent more toxins to be removed from the blood of dialysis patients. Use of this technology may result in patients with kidney disease seeing a considerable reduction in the length of dialysis sessions. An initial patent application for this technology was filed in 2011.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Shannath L Merbs, MD Po Box 64481, Baltimore, MD 21264-4481 Ph: (410) 955-5080 | Shannath L Merbs, MD 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-5080 |
News Archive
More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy, when anti-seizure medications don't work, according to a Rutgers coauthored study that may help lead to tailored treatments.
A new study describes the beneficial effect of an extract of Artemisia annua when used to treat cells in culture exposed to SARS-CoV-2.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
As part of its plan to expand access to a wide array of outpatient services, NYU Langone Medical Center has opened a new 327,000 square-foot Ambulatory Care Center (ACC) at 240 East 38th Street.
Researchers at Charité - Universitätsmedizin Berlin have developed a biophysical treatment method that allows up to 50 percent more toxins to be removed from the blood of dialysis patients. Use of this technology may result in patients with kidney disease seeing a considerable reduction in the length of dialysis sessions. An initial patent application for this technology was filed in 2011.
› Verified 6 days ago
Dr. Pradeep Y Ramulu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6052 | |
Ashley Behrens, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N. Wolfe Street, Baltimore, MD 21287 Phone: 410-502-0461 | |
Neil R Miller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-5080 | |
Dr. Allan Griffiths Scott, M.D Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6231 N Charles St, Baltimore, MD 21212 Phone: 410-377-2044 Fax: 410-377-8061 | |
Lily T Im, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 W Redwood St, Suite 479, Baltimore, MD 21201 Phone: 410-328-5918 Fax: 410-328-6346 | |
Brinda Muthusamy, MBCHB Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: The Wilmer Eye Institute Johns, 600 North Wolfe Street, Baltimore, MD 21287 Phone: 410-955-8314 | |
Israel Jesus Mendez, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21264 Phone: 410-955-5080 |